Who is sponsoring NCT07022730?

NCT07022730 is sponsored by Cairo University.

What drugs are being tested in NCT07022730?

Interventions in NCT07022730: Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction.

What condition does NCT07022730 study?

NCT07022730 studies Post Induction Hypotension, Sepsis.

Is NCT07022730 still recruiting?

NCT07022730 is currently completed. Last updated 18 September 2025.

Last reviewed 2025-09-18 · How we verify

NCT07022730

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension

Completed NA Last updated 18 September 2025

What this trial tests

NA trial testing Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction in Post Induction Hypotension in 80 participants. Completed in 17 September 2025.

Timeline

22 June 2025

Primary endpoint
17 September 2025

17 September 2025

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	80
Start date	22 June 2025
Primary completion	17 September 2025
Estimated completion	17 September 2025
Sites	1 location across Egypt

Drugs / interventions tested

Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction — full drug profile →

Conditions studied

Post Induction Hypotension — all drugs for Post Induction Hypotension →
Sepsis — all drugs for Sepsis →

Sponsor

Cairo University

Who can join

Adults 20 to 65, any sex, with Post Induction Hypotension or Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

researchers aim to evaluate the influence of prophylactic noradrenaline infusion on post-induction hypotension

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Preemptive noradrenaline infusion: a game-changer against post-induction hypotension in surgical sepsis: a randomized double blind trial.
Helmy MA, Mostafa MS, Saber AT, Ali MA, et al · · 2026 · PMID 41965525 · DOI 10.1186/s12871-026-03783-2

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07022730 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 18 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07022730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing